doi: 10.1016/j.biocel.2006.07.001 29 WinkDAHinesHBChengRYSwitzerCHFlores-SantanaWVitekMPet al
CS has wide antibacterial spectrum of activity and high killing rate against Gram-positive and Gram-negative bacteria and low toxicity toward mammalian cells
Planta 143:285289 Ferretti M, Destro T, Tosatto SCE, La Rocca N, Rascio N, Masi A (2009) Gamma-glutamyltransferase in the cell wall participates in extracellular glutathione salvage from the root apoplast
NAD IV therapy Miami providers offer is usually described as cellular wellness support
& Joerger, A
Potential benefits being investigated include: Cognitive performance : Some small-scale human studies have shown mixed results on cognitive tasks among participants receiving GLP-1 receptor agonists, with no consistent pattern of improvement established in randomised trials to date Cognitive decline : Observational data from diabetes cohorts suggest that patients prescribed GLP-1 agents may experience different rates of cognitive deterioration compared to those on other diabetes medications, though causality cannot be established Dementia risk : Population-based studies have indicated a possible association between GLP-1 receptor agonist use and dementia diagnoses, though these findings require confirmation in prospective trials Neuroimaging markers : Early research is examining potential effects on brain structure and function, but definitive evidence of preservation of brain volume has not been established Important limitations and considerations: Limited human trial data : Most evidence comes from animal models or observational studies
